Cargando…
Gliosarcoma Is Driven by Alterations in PI3K/Akt, RAS/MAPK Pathways and Characterized by Collagen Gene Expression Signature
Gliosarcoma is a very rare brain tumor reported to be a variant of glioblastoma (GBM), IDH-wildtype. While differences in molecular and histological features between gliosarcoma and GBM were reported, detailed information on the genetic background of this tumor is lacking. We intend to fill in this...
Autores principales: | Wojtas, Bartosz, Gielniewski, Bartlomiej, Wojnicki, Kamil, Maleszewska, Marta, Mondal, Shamba S., Nauman, Pawel, Grajkowska, Wieslawa, Glass, Rainer, Schüller, Ulrich, Herold-Mende, Christel, Kaminska, Bozena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468745/ https://www.ncbi.nlm.nih.gov/pubmed/30818875 http://dx.doi.org/10.3390/cancers11030284 |
Ejemplares similares
-
ECOA-6. Genomic and transcriptomic analyses reveal diverse mechanisms responsible for deregulation of epigenetic enzyme/modifier expression in glioblastoma
por: Maleszewska, Marta, et al.
Publicado: (2021) -
Aberrantly Expressed RECQL4 Helicase Supports Proliferation and Drug Resistance of Human Glioma Cells and Glioma Stem Cells
por: Król, Sylwia K., et al.
Publicado: (2020) -
BLM helicase overexpressed in human gliomas contributes to diverse responses of human glioma cells to chemotherapy
por: Wojnicki, Kamil, et al.
Publicado: (2023) -
EGFR/FOXO3a/BIM signaling pathway determines chemosensitivity of BMP4-differentiated glioma stem cells to temozolomide
por: Ciechomska, Iwona Anna, et al.
Publicado: (2020) -
Exploring Novel Therapeutic Opportunities for Glioblastoma Using Patient-Derived Cell Cultures
por: Ciechomska, Iwona A., et al.
Publicado: (2023)